Literature DB >> 30723908

The development of ovarian tissue cryopreservation in Edinburgh: Translation from a rodent model through validation in a large mammal and then into clinical practice.

Richard A Anderson1, David T Baird1.   

Abstract

Ovarian tissue cryopreservation has developed rapidly from its origins in experiments in sheep in the 1990s, and is now becoming recognized as a standard, rather than experimental, procedure. This review summarizes the origins of the technique, and key milestones in its development since the first reported sheep pregnancy in 1994 to the first successful human pregnancy in 2004, and now to the first baby born following cryopreservation of prepubertal ovarian tissue. Many challenges remain to optimize this technique, to improve the survival of follicles within the reimplanted ovarian tissue, to improve its reproducibility and hence the success rate and the lifespan of the graft. The other key area remains the possibility of the grafted tissue containing malignant cells, most importantly in leukemia.
© 2019 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  chemotherapy; fertility preservation; ovarian tissue cryopreservation; ovarian transplantation; ovary

Mesh:

Substances:

Year:  2019        PMID: 30723908     DOI: 10.1111/aogs.13560

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  9 in total

1.  Failure to focus seems to be a hominid thing.

Authors:  David F Albertini
Journal:  J Assist Reprod Genet       Date:  2022-03       Impact factor: 3.412

2.  Fertility preservation makes its mark: more than a sub-subspeciality.

Authors:  David F Albertini
Journal:  J Assist Reprod Genet       Date:  2022-08       Impact factor: 3.357

3.  Cryopreservation and Transplantation of Laboratory Rodent Ovarian Tissue for Genome Banking and Biomedical Research.

Authors:  Yuksel Agca; Cansu Agca
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Delaying Reproductive Aging by Ovarian Tissue Cryopreservation and Transplantation: Is it Prime Time?

Authors:  Kutluk H Oktay; Loris Marin; Boris Petrikovsky; Michael Terrani; Samir N Babayev
Journal:  Trends Mol Med       Date:  2021-02-04       Impact factor: 15.272

Review 5.  Fertility preservation for young adults, adolescents, and children with cancer.

Authors:  Kenny A Rodriguez-Wallberg; Amandine Anastacio; Emelie Vonheim; Sandra Deen; Johan Malmros; Birgit Borgström
Journal:  Ups J Med Sci       Date:  2020-05-01       Impact factor: 2.384

6.  Why are women considering ovarian tissue cryopreservation to preserve reproductive and hormonal ovarian function? A qualitative study protocol.

Authors:  Hajra Khattak; Ioannis Gallos; Arri Coomarasamy; A E Topping
Journal:  BMJ Open       Date:  2022-04-13       Impact factor: 3.006

7.  White paper: Oncofertility in pediatric patients with Wilms tumor.

Authors:  M E Madeleine van der Perk; Nicholas G Cost; Annelies M E Bos; Robert Brannigan; Tanzina Chowdhury; Andrew M Davidoff; Najat C Daw; Jeffrey S Dome; Peter Ehrlich; Norbert Graf; James Geller; John Kalapurakal; Kathleen Kieran; Marcus Malek; Mary F McAleer; Elizabeth Mullen; Luke Pater; Angela Polanco; Rodrigo Romao; Amanda F Saltzman; Amy L Walz; Andrew D Woods; Marry M van den Heuvel-Eibrink; Conrad V Fernandez
Journal:  Int J Cancer       Date:  2022-05-11       Impact factor: 7.316

Review 8.  Human Follicle in vitro Culture Including Activation, Growth, and Maturation: A Review of Research Progress.

Authors:  Qiyu Yang; Lixia Zhu; Lei Jin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

Review 9.  Progress and challenges in developing organoids in farm animal species for the study of reproduction and their applications to reproductive biotechnologies.

Authors:  Guillaume Bourdon; Véronique Cadoret; Gilles Charpigny; Anne Couturier-Tarrade; Rozenn Dalbies-Tran; Maria-José Flores; Pascal Froment; Mariam Raliou; Karine Reynaud; Marie Saint-Dizier; Alice Jouneau
Journal:  Vet Res       Date:  2021-03-10       Impact factor: 3.683

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.